Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
Oct 4 BBIO 3 Top Stocks That Could Still Rocket Higher in 2024
Oct 3 BBIO BridgeBio granted Perform rating at Oppenheimer on market challenges
Oct 3 SRPT Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics
Oct 3 BBIO BridgeBio to Present Outcomes Data Through 42 Months from the Open-Label Extension of ATTRibute-CM, the Phase 3 Study of Acoramidis for Treatment of ATTR-CM, at 2024 AHA Scientific Sessions
Oct 3 NBIX Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Oct 2 NBIX The Play On Neurocrine Biosciences
Oct 1 SRPT Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher
Oct 1 SVRA Savara Announces Patient Journey Map for People Living with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Accepted for Poster Presentation at the CHEST 2024 Annual Meeting
Oct 1 BBIO 5 FDA decisions to watch in the fourth quarter
Sep 30 NBIX Neurocrine touts long-term effectiveness of Ingrezza for Huntington's disease chorea
Sep 30 BBIO BridgeBio Pharma's Lead Candidate Cuts Mortality, Related Hospitalizations In Patients With Certain Type Of Heart Disease
Sep 30 SRPT Is Sarepta Therapeutics, Inc. (SRPT) One of the Best Revenue Growth Stocks to Buy According to Analysts?
Sep 30 NBIX Neurocrine Biosciences Presents Interim Data Demonstrating Robust and Sustained Improvements in Chorea Associated With Huntington's Disease Through Week 104 Irrespective of Antipsychotic Use
Sep 30 BBIO BridgeBio Completes Enrollment of FORTIFY, Phase 3 Registrational Study of BBP-418 in Limb-girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9)
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags